Your browser doesn't support javascript.
loading
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.
Li, Minghao; Richter, Susan; Mohr, Hermine; Drukewitz, Stephan; Poser, Isabel; Stanke, Daniela; Calsina, Bruna; Martinez-Montes, Angel M; Quinkler, Marcus; Timmers, Henri J L M; Nölting, Svenja; Beuschlein, Felix; Remde, Hanna; Opocher, Giuseppe; Rapizzi, Elena; Pacak, Karel; Pamporaki, Christina; Robledo, Mercedes; Liu, Longfei; Jiang, Jingjing; Bornstein, Stefan R; Eisenhofer, Graeme; Fliedner, Stephanie M J; Bechmann, Nicole.
Afiliação
  • Li M; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany.
  • Richter S; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
  • Mohr H; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Drukewitz S; Institute for Diabetes and Cancer, Helmholtz Centre Munich, Neuherberg, Germany.
  • Poser I; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
  • Stanke D; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
  • Calsina B; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Martinez-Montes AM; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Quinkler M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Timmers HJLM; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Nölting S; Endocrinology in Charlottenburg, Berlin, Germany.
  • Beuschlein F; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Remde H; Medizinische Klinik Und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany.
  • Opocher G; Department of Endocrinology, Diabetology and Clinical Nutrition, Universitätsspital Zürich (USZ) and University of Zurich (UZH), Zurich, Switzerland.
  • Rapizzi E; Medizinische Klinik Und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany.
  • Pacak K; Department of Endocrinology, Diabetology and Clinical Nutrition, Universitätsspital Zürich (USZ) and University of Zurich (UZH), Zurich, Switzerland.
  • Pamporaki C; Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital of Würzburg, Würzburg, Germany.
  • Robledo M; Department of Medicine, University of Padua, Padua, Italy.
  • Liu L; Department of Experimental and Clinical Medicine, University of Florence, Italy.
  • Jiang J; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States.
  • Bornstein SR; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany.
  • Eisenhofer G; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Fliedner SMJ; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
  • Bechmann N; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
Endocr Relat Cancer ; 30(12)2023 12 01.
Article em En | MEDLINE | ID: mdl-37902037

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article